Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • travelk
    Member
    • Jul 2013
    • 20

    #1

    Spearman correlation test: FPKM or counts?

    I'm not sure if this is very obvious but I'm not a statistician so I thought I would confirm with the more knowledgeable people on this site.


    I would like to do a Spearman correlation between genes on my RNA-Seq data (which I've seen done in various papers). However, they only say "Spearman correlation on gene expression data" and I don't know if that means on counts or FPKM. I've looked around and some papers do FPKM/RPKM (but not necessarily between genes but rather between conditions/treatments) but in message boards, they normally recommend counts but without explaining why. Can anyone enlighten me? Is there any difference between the two?

    I've normalized the counts using DESeq size factors.

    Thanks for your insight!
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    RPKM is counts, but corrected for differences in gene length between genes, and differences in overall read numbers between samples. You certainly do need to correct for the fact that not all samples get the same # of reads; you don't want one sample ranking as #1 for every gene because it got twice as many reads as everything else. Correcting for gene length is likely not going to matter since you are ranking.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    4 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...